Global Pharmacogenomics Market 2022-2028
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global pharmacogenomics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmacogenomics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for pharmacogenomics can be segmented By product: consumables, instruments, software. Pharmacogenomics market is further segmented By technology: microarray, polymerase chain reaction (PCR), sequencing, others. Based on application, the pharmacogenomics market is segmented into: cardiovascular diseases, neurology and psychiatry, oncology, respiratory and inflammatory diseases, others. On the basis of end user, the pharmacogenomics market also can be divided into: hospitals and clinics, independent testing laboratories, research institutions, others. Pharmacogenomics market by region is categorized into: North America, Europe, Asia-Pacific, Rest of the World.
By product:
- consumables
- instruments
- software
By technology:
- microarray
- polymerase chain reaction (PCR)
- sequencing
- others
By applicationt:
- cardiovascular diseases
- neurology and psychiatry
- oncology
- respiratory and inflammatory diseases
- others
By end user:- hospitals and clinics
- independent testing laboratories
- research institutions
- others
By region:
- North America
- Europe
- Asia-Pacific
- Rest of the World
The report explores the recent developments and profiles of key vendors in the Global Pharmacogenomics Market, including Abbott Laboratories, Agilent Technologies, Inc, Becton, Dickinson and Company, BGI Group Inc., Bio-Rad Laboratories, Inc., Diatech Pharmacogenetics S.R.L., Dynamic DNA Laboratories, F. Hoffmann-La Roche AG, Illumina, Inc, LGC Biosearch Technologies, Mesa Labs, Inc. (Agena Bioscience, Inc.), Myriad Genetics, Inc, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Qiagen N.V., Thermo Fisher Scientific Inc, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global pharmacogenomics market.
- To classify and forecast the global pharmacogenomics market based on product, technology, application, end user, region.
- To identify drivers and challenges for the global pharmacogenomics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmacogenomics market.
- To identify and analyze the profile of leading players operating in the global pharmacogenomics market.
Why Choose This Report
- Gain a reliable outlook of the global pharmacogenomics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
Consumables
Instruments
Software
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
Microarray
Polymerase chain reaction (PCR)
Sequencing
Others
PART 7. MARKET BREAKDOWN BY APPLICATION
Cardiovascular diseases
Neurology and psychiatry
Oncology
Respiratory and inflammatory diseases
Others
PART 8. MARKET BREAKDOWN BY END USER
Hospitals and clinics
Independent testing laboratories
Research institutions
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
Rest of the World
PART 10. KEY COMPANIES
Abbott Laboratories
Agilent Technologies, Inc
Becton, Dickinson and Company
BGI Group Inc.
Bio-Rad Laboratories, Inc.
Diatech Pharmacogenetics S.R.L.
Dynamic DNA Laboratories
F. Hoffmann-La Roche AG
Illumina, Inc
LGC Biosearch Technologies
Mesa Labs, Inc. (Agena Bioscience, Inc.)
Myriad Genetics, Inc
Oxford Nanopore Technologies Limited
Pacific Biosciences of California, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Pharmacogenomics (PGX) Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries
The Global market for Pharmacogenomics (PGX) is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027, from
USD 2960 View ReportGlobal Pharmacogenomics Technology Market Research Report 2019-2023
Pharmacogenomics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs. In the context of China-US trade war and global economic volatility
USD 2850 View ReportFill The Form For Sample Request